Retrospective Assessment of Initial Stroke Severity: Comparison of the NIH Stroke Scale and the Canadian Neurological Scale

Background and Purpose— The NIH Stroke Scale (NIHSS) and the Canadian Neurological Scale (CNS) have been reported to be useful for the retrospective assessment of initial stroke severity. However, unlike the CNS, the NIHSS requires detailed neurological assessments that may not be reflected in all patient records, potentially limiting its applicability. We assessed the reliability of the retrospective algorithms and the proportions of missing items for the NIHSS and CNS in stroke patients admitted to an academic medical center (AMC) and 2 community hospitals. Methods— Randomly selected records of patients with ischemic stroke admitted to an AMC (n=20) and community hospitals with (CH1, n=19) and without (CH2, n=20) acute neurological consultative services were reviewed. NIHSS and CNS scores were assigned independently by 2 neurologists using published algorithms. Interrater reliability of the scores was determined with the intraclass correlation coefficient, and the numbers of missing items were tabulated. Results— The intraclass correlation coefficient for NIHSS and CNS, respectively, were 0.93 (95% CI, 0.82 to 1.00) and 0.97 (95% CI, 0.90 to 1.00) for the AMC, 0.89 (95% CI, 0.75 to 1.00) and 0.88 (95%, 0.73 to 1.00) for the CH1, and 0.48 (95% CI, 0.26 to 0.70) and 0.78 (95% CI, 0.60 to 0.96) for the CH2. More NIHSS items were missing at the CH2 (62%) versus the AMC (27%) and the CH1 (23%, P =0.0001). In comparison, 33%, 0%, and 8% of CNS items were missing from records from CH2, AMC, and CH1, respectively (P =0.0001). Conclusions— The levels of interrater agreement were almost perfect for retrospectively assigned NIHSS and CNS scores for patients initially evaluated by a neurologist at both an AMC and a CH. Levels of agreement for the CNS were substantial at a CH2, but interrater agreement for the NIHSS was only moderate in this setting. The proportions of missing items are higher for the NIHSS than the CNS in each setting, particularly limiting its application in the hospital without acute neurological consultative services.

[1]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[2]  A. Feinstein,et al.  High agreement but low kappa: II. Resolving the paradoxes. , 1990, Journal of clinical epidemiology.

[3]  L. Goldstein,et al.  Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. , 1997, Stroke.

[4]  A R Localio,et al.  Reliability and validity of estimating the NIH stroke scale score from medical records. , 1999, Stroke.

[5]  A. Feinstein,et al.  Clinical biostatistics: LIV. The biostatistics of concordance , 1981 .

[6]  L. Williams,et al.  Retrospective assessment of initial stroke severity with the NIH Stroke Scale. , 2000, Stroke.

[7]  L. Jongbloed Prediction of function after stroke: a critical review. , 1986, Stroke.

[8]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[9]  C. Borel,et al.  Survival and outcome after endotracheal intubation for acute stroke , 1999, Neurology.

[10]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[11]  V Hachinski,et al.  The Canadian Neurological Scale , 1989, Neurology.

[12]  C. Allen Predicting the outcome of acute stroke: a prognostic score. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[13]  G. Murray,et al.  Comparison of neurological scales and scoring systems for acute stroke prognosis. , 1996, Stroke.

[14]  S. Attar,et al.  Mitral valve replacement. , 1965, Maryland state medical journal.

[15]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[16]  D B Matchar,et al.  What role do neurologists play in determining the costs and outcomes of stroke patients? , 1996, Stroke.

[17]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[18]  A. Feinstein,et al.  High agreement but low kappa: I. The problems of two paradoxes. , 1990, Journal of clinical epidemiology.

[19]  G. MacKenzie,et al.  Prognostic indices in stroke. , 1988, The Quarterly journal of medicine.

[20]  Gunnar B. Stickler,et al.  Prognosis , 1970 .